He pointed out that the distinction between a Routine I drug (like LSD) and a Program II drug (like OxyContin) is just that the latter continues to be identified for a selected health care objective. “Otherwise there’s no variance. They’re the two equally perilous,” he explained. CNS disruptor (stimulant and hallucinogenic effect): https://zbookmarkhub.com/story19659257/new-step-by-step-map-for-usa-copyright-shipping